Stacey A. Missmer (4243072)

No ORCID on file · 23 papers in corpus · active 2019-2024

Study types

  • dataset 19
  • other 4

Condition tags

  • endometriosis 23
  • chronic_pelvic_pain 7
  • dysmenorrhea 7
  • dyspareunia 6
  • interstitial_cystitis 6
  • infertility 1
  • adenomyosis 1
other 2024
·doi:10.3389/frph.2024.1360417.s001

IntroductionPrior studies have investigated the diagnostic potential of microRNA (miRNA) expression profiles for endometriosis. However, the vast majority of previous studies have only included adult women. Therefore, we sought to investiga…

other 2024
·doi:10.3389/frph.2024.1360417.s002

IntroductionPrior studies have investigated the diagnostic potential of microRNA (miRNA) expression profiles for endometriosis. However, the vast majority of previous studies have only included adult women. Therefore, we sought to investiga…

dataset 2024
·doi:10.3389/frph.2024.1360417.s003

IntroductionPrior studies have investigated the diagnostic potential of microRNA (miRNA) expression profiles for endometriosis. However, the vast majority of previous studies have only included adult women. Therefore, we sought to investiga…

dataset 2024
·doi:10.3389/frph.2024.1360417.s004

IntroductionPrior studies have investigated the diagnostic potential of microRNA (miRNA) expression profiles for endometriosis. However, the vast majority of previous studies have only included adult women. Therefore, we sought to investiga…

dataset 2024
·doi:10.3389/frph.2024.1360417.s005

IntroductionPrior studies have investigated the diagnostic potential of microRNA (miRNA) expression profiles for endometriosis. However, the vast majority of previous studies have only included adult women. Therefore, we sought to investiga…

dataset 2024
·doi:10.3389/frph.2024.1360417.s006

IntroductionPrior studies have investigated the diagnostic potential of microRNA (miRNA) expression profiles for endometriosis. However, the vast majority of previous studies have only included adult women. Therefore, we sought to investiga…

dataset 2023
·doi:10.3389/frph.2023.1140857.s001

IntroductionChronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid condi…

dataset 2023
·doi:10.3389/frph.2023.1297907.s001

BackgroundPeritoneal fluid is a medium for endometriosis-associated biomarker discovery from which the local peritoneal environment and pathophysiologic pathways are often inferred. Therefore, we evaluated the associations between peritonea…

dataset 2023
·doi:10.3389/frph.2023.1140857.s002

IntroductionChronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid condi…

dataset 2023
·doi:10.3389/frph.2023.1140857.s003

IntroductionChronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid condi…

dataset 2023
·doi:10.3389/frph.2023.1140857.s004

IntroductionChronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid condi…

dataset 2023
·doi:10.3389/frph.2023.1140857.s005

IntroductionChronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid condi…

dataset 2023
·doi:10.3389/frph.2023.1140857.s006

IntroductionChronic pelvic pain (CPP) is a common condition affecting up to 26.6% of women, with many suffering for several years before diagnosis and/or treatment. Its clinical presentation is varied and there are frequently comorbid condi…

dataset 2022
·doi:10.1371/journal.pone.0269858.t002
dataset 2021
·doi:10.3389/frph.2021.661360.s001

Introduction: High prevalence of gynecological conditions in women of Middle Eastern origin is reported, likely due to regional risk factors and mediators. The objective of this systematic review and meta-analysis is to investigate the prev…

dataset 2021
·doi:10.3389/fgwh.2021.644609.s001

Endometriosis affects 10% of women worldwide and is one of the most common causes of chronic pelvic pain and infertility. However, causal mechanisms of this disease remain unknown due to its heterogeneous presentation. In order to successfu…

dataset 2020
·doi:10.1371/journal.pone.0238043.t001

Association between demographic/reproductive factors and circulating CA125 among surgically confirmed endometriosis cases and controlsa.

dataset 2020
·doi:10.1371/journal.pone.0238043.t002

Association between pain symptoms and circulating CA125 among surgically confirmed endometriosis cases and controlsa.

other 2020
·doi:10.1371/journal.pone.0238043.g001

(A) Receiver Operating Curves (ROC) using CA125 cutoff of 35 U/mL and (B) using CA125 cutoff of 30 U/mL among participants presenting with dysmenorrhea (overall = solid line; mild pain = dashed line; moderate pain = dotted line; severe pain…

other 2019
·doi:10.1371/journal.pone.0222889.g002

Bars represent the annual endometriosis-related inpatient admission rate per 100,000; solid line represents total inpatient admissions in millions.

dataset 2019
·doi:10.1371/journal.pone.0222889.t001

Patient and hospital characteristics of women with an inpatient admission for endometriosis (ICD-9 code 617.xx) within time-period-defined cohorts.

dataset 2019
·doi:10.1371/journal.pone.0222889.t003

Trends in surgical procedures reported in inpatients visits for endometriosis across cohorts.

dataset 2019
·doi:10.1371/journal.pone.0222889.t002

Trends in the prevalence of comorbidities among women with an inpatient admission for endometriosis (ICD-9 code 617.xx) within time-period-defined cohorts.